Zymergi LogoCart

483 Document: BioMarin Pharmaceutical Inc., Dec 9, 2022

FDANews 483 BioMarin Pharmaceutical Inc. Dec 9 2022 top
Thomas R. Withers FDA Investigator Laura Fontan FDA Investigator Andrew W. Harmon FDA Investigator Emmanuel Adu-Gyamfi FDA Investigator Kula N. Jha FDA Investigator

On Dec 09, 2022, the FDA inspected BioMarin Pharmaceutical Inc.'s Novato site. Explore the inspectional observations.